Apogee Therapeutics (APGE) Director Nimish P. Shah Receives Option Award

What Happened Nimish P. Shah, a director of Apogee Therapeutics (APGE), was granted a derivative award on 2026-06-09 giving him the right to purchase 7,657 shares of the company's common stock. The Form 4 reports the grant at $0.00 (no cash paid on grant) and does not show any immediate sale or exercise.

Key Details

• Transaction date: 2026-06-09; Form 4 filed: 2026-06-11.
• Grant type: Derivative award (option) for 7,657 shares, reported at $0.00.
• Vesting: The option vests on the one-year anniversary of the grant date, subject to continued service. (Footnote F1)
• Beneficial ownership note: Under an agreement with Venrock Management, LLC, Shah is deemed to hold the option for the sole benefit of the Management Company; Venrock may be the indirect beneficial owner and Shah disclaims beneficial ownership except for any pecuniary interest. (Footnote F2)
• Filing timeliness: Reported within two days of the transaction; no late filing flag in the record.

Context This is a standard equity incentive grant to a director rather than a purchase or sale in the open market. It does not represent exercised options or a cash transaction; shares will only be issuable if and when the option vests and is exercised. The filing also indicates the option is effectively held for the benefit of Venrock Management, which may be the ultimate beneficial owner.